224 related articles for article (PubMed ID: 22641175)
1. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
[TBL] [Abstract][Full Text] [Related]
2. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
3. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
5. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
Yu W; Ma Y; Shankar S; Srivastava RK
Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
[TBL] [Abstract][Full Text] [Related]
6. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
[TBL] [Abstract][Full Text] [Related]
7. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
[TBL] [Abstract][Full Text] [Related]
8. The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways.
Gu YY; Yang M; Zhao M; Luo Q; Yang L; Peng H; Wang J; Huang SK; Zheng ZX; Yuan XH; Liu P; Huang CZ
Tumour Biol; 2015 Nov; 36(11):8379-87. PubMed ID: 26018507
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.
Li C; Liu J; Zhang Q; Cui K; Ge Q; Wang C; Chen Z
Int J Oncol; 2018 Jun; 52(6):1815-1826. PubMed ID: 29620261
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
11. A Selective Inhibitor of Ubiquitin-Specific Protease 4 Suppresses Colorectal Cancer Progression by Regulating β-Catenin Signaling.
Nguyen HH; Kim T; Nguyen T; Hahn MJ; Yun SI; Kim KK
Cell Physiol Biochem; 2019; 53(1):157-171. PubMed ID: 31251006
[TBL] [Abstract][Full Text] [Related]
12. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
[TBL] [Abstract][Full Text] [Related]
15. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
16. Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling.
Bheda A; Yue W; Gullapalli A; Whitehurst C; Liu R; Pagano JS; Shackelford J
PLoS One; 2009 Jun; 4(6):e5955. PubMed ID: 19536331
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.
Liu S; González-Prieto R; Zhang M; Geurink PP; Kooij R; Iyengar PV; van Dinther M; Bos E; Zhang X; Le Dévédec SE; van de Water B; Koning RI; Zhu HJ; Mesker WE; Vertegaal ACO; Ovaa H; Zhang L; Martens JWM; Ten Dijke P
Clin Cancer Res; 2020 Mar; 26(6):1460-1473. PubMed ID: 31857432
[TBL] [Abstract][Full Text] [Related]
18. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
19. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer.
Yun SI; Kim HH; Yoon JH; Park WS; Hahn MJ; Kim HC; Chung CH; Kim KK
Mol Oncol; 2015 Nov; 9(9):1834-51. PubMed ID: 26189775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]